These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 4780897)
61. [Psychiatric and neurological symptoms caused by cycloserine poisoning]. Nakamura K Seishin Shinkeigaku Zasshi; 1968 Jun; 70(6):503-21. PubMed ID: 5749977 [No Abstract] [Full Text] [Related]
62. [5-year assessment of daily multi-drug therapy of leprosy in Guadeloupe since 1980]. Cartel JC; Gallais JJ; Naudillon Y; Millan J; Grosset JH Acta Leprol; 1986; 4(4):415-25. PubMed ID: 3296612 [TBL] [Abstract][Full Text] [Related]
63. [Tuberculosis in children in 1989]. Tournier G Pediatrie; 1989; 44(9):687-9. PubMed ID: 2622710 [No Abstract] [Full Text] [Related]
64. A plan of leprosy control in Nepal being carried out in a general hospital. Pedley JC Lepr Rev; 1969 Oct; 40(4):249-50. PubMed ID: 5385252 [No Abstract] [Full Text] [Related]
65. Diabetes in Malta. A pilot survey. Maempel JV Lancet; 1965 Dec; 2(7424):1197-200. PubMed ID: 4158819 [No Abstract] [Full Text] [Related]
66. Leprosy in the Americas region (AMRO). Motta CP Lepr Rev; 1980 Dec; 51(4):285-94. PubMed ID: 7219014 [No Abstract] [Full Text] [Related]
67. The measurement of the epidemiological impact of multidrug therapy. Pirayavaraporn C; Peerapakorn S Lepr Rev; 1992 Sep; 63 Suppl 1():84s-92s. PubMed ID: 1406042 [No Abstract] [Full Text] [Related]
69. First results of treatment of leprosy with Rifadin. Leiker DL; Kamp H Lepr Rev; 1970 Jan; 41(1):25-30. PubMed ID: 5441927 [No Abstract] [Full Text] [Related]
70. A report on two follow-up investigations of the Malta-Project. Jopling WH Lepr Rev; 1986; 57 Suppl 3():47-52. PubMed ID: 3573960 [No Abstract] [Full Text] [Related]
71. "Mobile" leprosy control in the Luapula Province of Zambia. Jogan B; Rogers I Lepr Rev; 1973 Sep; 44(3):120-6. PubMed ID: 4788876 [No Abstract] [Full Text] [Related]
72. Studies on the treatment of leprosy with a synthesized thiocarbanilide derivative L-4. Lew J; Chang CH; Choi TK Yonsei Med J; 1968; 9(1):24-37. PubMed ID: 5715900 [No Abstract] [Full Text] [Related]
74. Leprosy--an update. Kakakhel K J Pak Med Assoc; 1990 Mar; 40(3):72-6. PubMed ID: 2113961 [No Abstract] [Full Text] [Related]
75. Treatment of acute exacerbations in leprosy with idomethacin. Parikh AC; Ganapati R Lepr Rev; 1968 Oct; 39(4):207-8. PubMed ID: 5722497 [No Abstract] [Full Text] [Related]
76. [Preliminary observations with ultra-delayed elimination sulfonamide in the treatment of leprosy]. Pereira Junior AC An Bras Dermatol; 1967; 42(1):35-45. PubMed ID: 5633700 [No Abstract] [Full Text] [Related]
77. Advances in the treatment of leprosy. Browne SG Practitioner; 1967 Oct; 119(192):525-31. PubMed ID: 6060683 [No Abstract] [Full Text] [Related]
79. The water supply problem in Malta. Vassallo A R Inst Public Health Hyg J; 1965 Sep; 28(9):248-58. PubMed ID: 5865243 [No Abstract] [Full Text] [Related]
80. The leprosy eradication-project of Malta. Agius-Ferrante A; Depasquale G; Bonnici E; Paris C; Grima W Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:49-52. PubMed ID: 4780897 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]